Home
Conditions
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity

Clinical trial condition

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity

Explore clinical trials studying Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity. Study availability and eligibility vary by location and protocol.

17 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity trial results

Recruiting

Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

NCT01473784

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +70 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.

NCT01469429

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +86 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors

NCT01504932

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +29 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

NCT02123511

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +98 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

State University of New York Upstate Medical University Syracuse, New York, United States

Bismarck Cancer Center Bismarck, North Dakota, United States

View Trial Details

Completed

TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck

NCT01334177

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +53 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

NCT00101348

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +122 more
Locations: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

NCT00049283

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +37 more
Locations: Case Western Reserve University Cleveland, Ohio, United States

View Trial Details

Completed

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

NCT00492089

Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Meningioma, +126 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00513435

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer

NCT00055770

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity trial results

Related conditions